190 related articles for article (PubMed ID: 27572116)
21. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes.
Hellum BH; Hu Z; Nilsen OG
Basic Clin Pharmacol Toxicol; 2007 Jan; 100(1):23-30. PubMed ID: 17214607
[TBL] [Abstract][Full Text] [Related]
22. Variability of Major Phenyletanes and Phenylpropanoids in 16-Year-Old
Elameen A; Kosman VM; Thomsen M; Pozharitskaya ON; Shikov AN
Molecules; 2020 Jul; 25(15):. PubMed ID: 32751483
[No Abstract] [Full Text] [Related]
23. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression.
Obach RS
J Pharmacol Exp Ther; 2000 Jul; 294(1):88-95. PubMed ID: 10871299
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous quantification of polyherbal formulations containing Rhodiola rosea L. and Eleutherococcus senticosus Maxim. using rapid resolution liquid chromatography (RRLC).
Ma YC; Wang XQ; Hou F; Ma J; Luo M; Lu S; Jin P; Chen A; Xu I; Patel AV; Gorecki D
J Pharm Biomed Anal; 2011 Jul; 55(5):908-15. PubMed ID: 21466940
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450.
Chiangsom A; Lawanprasert S; Oda S; Kulthong K; Luechapudiporn R; Yokoi T; Maniratanachote R
Drug Metab Pharmacokinet; 2016 Jun; 31(3):210-7. PubMed ID: 27212065
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.
Yale SH; Glurich I
J Altern Complement Med; 2005 Jun; 11(3):433-9. PubMed ID: 15992226
[TBL] [Abstract][Full Text] [Related]
27. Rhodiola rosea root extract has antipsychotic-like effects in rodent models of sensorimotor gating.
Coors A; Brosch M; Kahl E; Khalil R; Michels B; Laub A; Franke K; Gerber B; Fendt M
J Ethnopharmacol; 2019 May; 235():320-328. PubMed ID: 30776471
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human drug metabolizing cytochrome P450 enzymes by plant isoquinoline alkaloids.
Salminen KA; Meyer A; Jerabkova L; Korhonen LE; Rahnasto M; Juvonen RO; Imming P; Raunio H
Phytomedicine; 2011 Apr; 18(6):533-8. PubMed ID: 20851588
[TBL] [Abstract][Full Text] [Related]
29. In vitro inhibition of human CYP1A2, CYP2D6, and CYP3A4 by six herbs commonly used in pregnancy.
Langhammer AJ; Nilsen OG
Phytother Res; 2014 Apr; 28(4):603-10. PubMed ID: 23843424
[TBL] [Abstract][Full Text] [Related]
30. Rhodiosin and herbacetin in
Péter Zomborszki Z; Kúsz N; Csupor D; Peschel W
Pharm Biol; 2019 Dec; 57(1):295-305. PubMed ID: 31356124
[No Abstract] [Full Text] [Related]
31. Analysis of the marker compounds of Rhodiola rosea L. (golden root) by reversed phase high performance liquid chromatography.
Ganzera M; Yayla Y; Khan IA
Chem Pharm Bull (Tokyo); 2001 Apr; 49(4):465-7. PubMed ID: 11310675
[TBL] [Abstract][Full Text] [Related]
32. Rhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy.
Nabavi SF; Braidy N; Orhan IE; Badiee A; Daglia M; Nabavi SM
Phytother Res; 2016 Apr; 30(4):532-9. PubMed ID: 27059687
[TBL] [Abstract][Full Text] [Related]
33. Anti-Inflammatory and Neuroprotective Effects of Constituents Isolated from Rhodiola rosea.
Lee Y; Jung JC; Jang S; Kim J; Ali Z; Khan IA; Oh S
Evid Based Complement Alternat Med; 2013; 2013():514049. PubMed ID: 23690847
[TBL] [Abstract][Full Text] [Related]
34. Phytochemical profile, in vitro bioaccessibility, and anticancer potential of golden root (Rhodiola rosea L.) extracts.
Sęczyk Ł; Sugier D; Dervişoğlu G; Özdemir FA; Kołodziej B
Food Chem; 2023 Mar; 404(Pt B):134779. PubMed ID: 36332586
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effects of gypenosides on seven human cytochrome P450 enzymes in vitro.
He M; Jiang J; Qiu F; Liu S; Peng P; Gao C; Miao P
Food Chem Toxicol; 2013 Jul; 57():262-5. PubMed ID: 23583485
[TBL] [Abstract][Full Text] [Related]
36. Authenticity and quality evaluation of different Rhodiola species and commercial products based on NMR-spectroscopy and HPLC.
Marchev AS; Koycheva IK; Aneva IY; Georgiev MI
Phytochem Anal; 2020 Nov; 31(6):756-769. PubMed ID: 32311178
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of cytochrome P450 enzymes CYP1A2, CYP2A6, CYP2E1 and CYP3A4 by extracts and alkaloids of Gelsemium elegans roots.
Wang Y; Wu S; Chen Z; Zhang H; Zhao W
J Ethnopharmacol; 2015 May; 166():66-73. PubMed ID: 25764964
[TBL] [Abstract][Full Text] [Related]
38. [Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine].
Kucinskaite A; Briedis V; Savickas A
Medicina (Kaunas); 2004; 40(7):614-9. PubMed ID: 15252224
[TBL] [Abstract][Full Text] [Related]
39. Running out of time to smell the roseroots: Reviewing threats and trade in wild Rhodiola rosea L.
Brinckmann JA; Cunningham AB; Harter DEV
J Ethnopharmacol; 2021 Apr; 269():113710. PubMed ID: 33358852
[TBL] [Abstract][Full Text] [Related]
40. Hydroalcoholic extract of Rhodiola rosea L. (Crassulaceae) and its hydrolysate inhibit melanogenesis in B16F0 cells by regulating the CREB/MITF/tyrosinase pathway.
Chiang HM; Chien YC; Wu CH; Kuo YH; Wu WC; Pan YY; Su YH; Wen KC
Food Chem Toxicol; 2014 Mar; 65():129-39. PubMed ID: 24380755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
